Cara Therapeutics, Inc. (0HTC.L) LSE

15.99

-0.7893(-4.70%)

Updated at September 02 02:58PM

Currency In USD

Valuation

Market Cap7.45M
Enterprise Value14M
P/E Ratio-12.28
PEG Ratio-0.24
Price/Sales Ratio44.33
Price/Book Ratio7.79
Enterprise/Revenue41.23
Enterprise/EBITDA-10.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-3.18
Operating Margin-3.58

Management Effectiveness

Return On Assets-0.48
Return On Equity1.43

Income Statement

Revenue7.14M
Revenue/Share0.8
Gross Profit6.33M
EBITDA-62.6M
Net Income-70.87M
Diluted EPS-46.59

Balance Sheet

Total Cash40.99M
Total Cash/Share4.97
Total Debt254,000
Total Debt/Equity0.01
Current Ratio4.04
Book Value Per Share3.99

Price History

52-Week Change318.59
52-Week High15.99
52-Week Low0.5
Moving Average 50 Days0.69
Moving Average 200 Days1.89

Statistics

Average Volume18,632
Shares Outstanding4.57M
% Held by Institutions41.57

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor83333:1000000
Last Split DateDecember 31, 2024